Foreign Discovery Mostly Denied In Zofran Birth Defect MDL
A Massachusetts federal judge on Thursday mostly rejected efforts by families suing GlaxoSmithKline over alleged links between birth defects and anti-nausea drug Zofran to get access to foreign regulatory files....To view the full article, register now.
Already a subscriber? Click here to view full article